|Articles|October 1, 2014
Dana-Farber Leads Kadcyla ATEMPT Study in HER2-Positive Breast Cancer
Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.
Advertisement
Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
"You Think It Won't Happen to You" — Teddi Mellencamp on Melanoma and Speaking Up
2
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
3
Living with Metastatic Cancer Means Loss in the Midst of Love
4
ZUSDURI and the ENVISION Trial: A Non-Surgical Path Forward for Recurrent Bladder Cancer
5